Maarten Boers (M Boers)

Publication Activity (10 Years)

Years Active: 2017-2024
Publications (10 Years): 68

Top Topics

Rheumatoid Arthritis

Disease Activity

Top Venues

Annals of the rheumatic diseases

The Journal of rheumatology

Arthritis care & research

This page only lists publications with an associated author ORCID identifier.

Publications

Carlijn A Wagenaar, Wendy Walrabenstein, Marike van der Leeden, Franktien Turkstra, Martijn Gerritsen, Jos W R Twisk, Maarten Boers, Martin van der Esch, Henriët van Middendorp, Peter J M Weijs, Dirkjan van Schaardenburg
Long-term effectiveness of a lifestyle intervention for rheumatoid arthritis and osteoarthritis: 1-year follow-up of the 'Plants for Joints' randomised clinical trial. RMD open 10 (1) (2024)
Carlijn A Wagenaar, Wendy Walrabenstein, Marike van der Leeden, Franktien Turkstra, Martijn Gerritsen, Jos W R Twisk, Maarten Boers, Martin van der Esch, Henriët van Middendorp, Peter J M Weijs, Dirkjan van Schaardenburg
Long-term effectiveness of a lifestyle intervention for rheumatoid arthritis and osteoarthritis: 1-year follow-up of the 'Plants for Joints' randomised clinical trial. RMD open 10 (1) (2024)
Carlijn A Wagenaar, Wendy Walrabenstein, Marike van der Leeden, Franktien Turkstra, Martijn Gerritsen, Jos W R Twisk, Maarten Boers, Martin van der Esch, Henriët van Middendorp, Peter J M Weijs, Dirkjan van Schaardenburg
Long-term effectiveness of a lifestyle intervention for rheumatoid arthritis and osteoarthritis: 1-year follow-up of the 'Plants for Joints' randomised clinical trial. RMD open 10 (1) (2024)
Jos Runhaar, Ömer Özbulut, Margreet Kloppenburg, Maarten Boers, Johannes W J Bijlsma, Sita Bierma-Zeinstra, null null
Two-year clinical follow-up enhances the diagnosis of early-stage hip osteoarthritis: data from check cohort. RMD open 10 (2) (2024)
Jos Runhaar, Ömer Özbulut, Margreet Kloppenburg, Maarten Boers, Johannes W J Bijlsma, Sita Bierma-Zeinstra, null null
Two-year clinical follow-up enhances the diagnosis of early-stage hip osteoarthritis: data from check cohort. RMD open 10 (2) (2024)
Jos Runhaar, Ömer Özbulut, Margreet Kloppenburg, Maarten Boers, Johannes W J Bijlsma, Sita Bierma-Zeinstra, null null
Two-year clinical follow-up enhances the diagnosis of early-stage hip osteoarthritis: data from check cohort. RMD open 10 (2) (2024)
Andriko Palmowski, Maarten Boers, John R Kirwan, Robin Christensen, Frank Buttgereit
The Effect of Low-Dose Glucocorticoids Over Two Years on Weight and Blood Pressure in Rheumatoid Arthritis. Annals of internal medicine 177 (4) (2024)
Andriko Palmowski, Sabrina Mai Nielsen, Zhivana Boyadzhieva, Linda Hartman, Judith Oldenkott, Björn Svensson, Ingiäld Hafström, Siegfried Wassenberg, Ernest H S Choy, John R Kirwan, Robin Christensen, Maarten Boers, Frank Buttgereit
The Effect of Low-Dose Glucocorticoids Over Two Years on Weight and Blood Pressure in Rheumatoid Arthritis: Individual Patient Data From Five Randomized Trials. Annals of internal medicine (2023)
Melek Güler-Yüksel, Martijn Kuijper, Reinhard Bos, Esmeralda Molenaar, Jasper Emmering, Sylvia Eshuis, Adams Human, Floor Reimann, Maarten Boers, Marc-Redwart Kok
Changes in body weight and body composition in patients with active rheumatoid arthritis aged 65+ treated with 2-year low-dose add-on prednisolone in the randomised double-blind placebo-controlled GLORIA trial. RMD open 9 (2) (2023)
Lidwine B Mokkink, Iris Eekhout, Maarten Boers, Cees P M van der Vleuten, Henrica C W de Vet
Studies on Reliability and Measurement Error of Measurements in Medicine - From Design to Statistics Explained for Medical Researchers. Patient related outcome measures 14 (2023)
Maarten Boers
Correspondence on "Testing different thresholds for patient global assessment in defining remission for rheumatoid arthritis: are the current ACR/EULAR Boolean criteria optimal?" by Studenic et al . Annals of the rheumatic diseases (2023)
Maarten Boers
Correspondence on "Testing different thresholds for patient global assessment in defining remission for rheumatoid arthritis: are the current ACR/EULAR Boolean criteria optimal?" by Studenic et al . Annals of the rheumatic diseases (2023)
Maarten Boers
Viewpoint: Glucocorticoids in the Treatment of Rheumatoid Arthritis: Points to (Re)consider. Rheumatology (Oxford, England) (2023)
Maarten Boers
Correspondence on "Testing different thresholds for patient global assessment in defining remission for rheumatoid arthritis: are the current ACR/EULAR Boolean criteria optimal?" by Studenic et al . Annals of the rheumatic diseases (2023)
Lotte van Ouwerkerk, Patrick Verschueren, Maarten Boers, Paul Emery, Pascal Hendrik Pieter de Jong, Robert B M Landewe, Willem F Lems, Josef S Smolen, Thomas Wj Huizinga, Cornelia F Allaart, Sytske Anne Bergstra
Initial glucocorticoid bridging in rheumatoid arthritis: does it affect glucocorticoid use over time? Annals of the rheumatic diseases (2023)
Qiuke Wang, Jos Runhaar, Margreet Kloppenburg, Maarten Boers, Johannes W J Bijlsma, Sita M A Bierma-Zeinstra, null null
Evaluation of the diagnostic performance of ACR, EULAR and NICE criteria against clinically relevant knee osteoarthritis; data from the CHECK cohort. Arthritis care & research (2023)
Maarten Boers
Correspondence on "Testing different thresholds for patient global assessment in defining remission for rheumatoid arthritis: are the current ACR/EULAR Boolean criteria optimal?" by Studenic et al . Annals of the rheumatic diseases (2023)
Melek Güler-Yüksel, Martijn Kuijper, Reinhard Bos, Esmeralda Molenaar, Jasper Emmering, Sylvia Eshuis, Adams Human, Floor Reimann, Maarten Boers, Marc-Redwart Kok
Changes in body weight and body composition in patients with active rheumatoid arthritis aged 65+ treated with 2-year low-dose add-on prednisolone in the randomised double-blind placebo-controlled GLORIA trial. RMD open 9 (2) (2023)
Abdullah Ali Hadi Almayali, Maarten Boers, Linda Hartman, Daniela Opris, Reinhard Bos, Marc-Redwart Kok, José António Pereira Da Silva, Ed Griep, Ruth Klaasen, Cornelia F Allaart, Paul Baudoin, Hennie G Raterman, Zoltán Szekanecz, Frank Buttgereit, Pavol Masaryk, Willem F Lems, Yvo Smulders, Maurizio Cutolo, Marieke M Ter Wee
Three-month tapering and discontinuation of long- term, low-dose glucocorticoids in senior patients with rheumatoid arthritis is feasible and safe: placebo-controlled double blind tapering after the GLORIA trial. Annals of the rheumatic diseases (2023)
Maarten Boers
Comment on: Rheumatoid arthritis disease activity and hospitalized infection in a large U.S. registry: some additional suggestions for analyses by Yun et al. Arthritis care & research (2022)
Laura Boekel, Femke Hooijberg, Erik H Vogelzang, Yaëlle R Besten, Maureen Leeuw, Sadaf Atiqi, Ronald F Van Vollenhoven, Carla A Wijbrandts, Martijn Gerritsen, Charlotte Lm Krieckaert, Bas Dijkshoorn, Siham Bakhlakh, Juliette J Crooijmans, Alexandre Voskuyl, Irene E van der Horst-Bruinsma, Willem F Lems, Taco W Kuijpers, S Marieke van Ham, Luuk Wieske, Filip Eftimov, Laura Y Kummer, Pj Koos van Dam, Eileen W Stalman, Maurice Steenhuis, Sofie Keijzer, Olvi Cristianawati, Jim Keijser, Floris C Loeff, Sander W Tas, Michael T Nurmohamed, Maarten Boers, Theo Rispens, Gertjan Wolbink
Antibody development and disease severity of COVID-19 in non-immunised patients with rheumatic immune-mediated inflammatory diseases: data from a prospective cohort study. RMD open 8 (1) (2022)
Nicki Verweij, Gerben Zwezerijnen, Marieke Ter Wee, Jerney de Jongh, Maqsood Yaqub, Dirkjan van Schaardenburg, Adriaan Lammertsma, Alexandre Voskuyl, Willem F Lems, Maarten Boers, Conny van der Laken
Early prediction of treatment response in rheumatoid arthritis by quantitative macrophage PET. RMD open 8 (1) (2022)
Ingrid M Visman, Maarten Boers, Daisy Vedder, Jos Wr Twisk, Michael T Nurmohamed
Routine treatment of rheumatoid arthritis with biologics and targeted agents: changes in patients and their response over 15 years. Annals of the rheumatic diseases (2022)
Lotte van Ouwerkerk, Maarten Boers, Paul Emery, Pascal Hendrik Pieter de Jong, Robert B M Landewe, Willem F Lems, Josef S Smolen, Patrick Verschueren, Thomas Wj Huizinga, Cornelia F Allaart, Sytske Anne Bergstra
Individual patient data meta-analysis on continued use of glucocorticoids after their initiation as bridging therapy in patients with rheumatoid arthritis. Annals of the rheumatic diseases (2022)
Maarten Boers, Linda Hartman, Daniela Opris-Belinski, Reinhard Bos, Marc-Redwart Kok, José António Pereira Da Silva, Eduard N Griep, Ruth Klaasen, Cornelia F Allaart, Paul Baudoin, Hennie G Raterman, Zoltán Szekanecz, Frank Buttgereit, Pavol Masaryk, L Thomas Klausch, Sabrina Paolino, Annemarie M Schilder, Willem F Lems, Maurizio Cutolo, null null
Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial. Annals of the rheumatic diseases 81 (7) (2022)
Maarten Boers
Three Months of Glucocorticoids in Rheumatoid Arthritis: A Bridge Too Short? Arthritis & rheumatology (Hoboken, N.J.) 74 (10) (2022)
Edgar Wiebe, Dörte Huscher, Désireé Schaumburg, Andriko Palmowski, Sandra Hermann, Thomas Buttgereit, Robert Biesen, Gerd-Rüdiger R Burmester, Yannick Palmowski, Maarten Boers, John H Stone, Christian Dejaco, Frank Buttgereit
Optimising both disease control and glucocorticoid dosing is essential for bone protection in patients with rheumatic disease. Annals of the rheumatic diseases (2022)
Marwan Bukhari, Nicola J Goodson, Maarten Boers
Comment on: Paradoxically protective effect of glucocorticoids on bone mass and fragility fracture in a large cohort: a cross-sectional study. Reply. Rheumatology advances in practice 6 (2) (2022)
Rianne Elise van Bentum, Frank D Verbraak, Sanne Wolf, Jenny Ongkosuwito, Maarten Boers, H Stevie Tan, Irene E van der Horst-Bruinsma
High Prevalence of Previously Undiagnosed Axial Spondyloarthritis in Patients Referred With Anterior Uveitis and Chronic Back Pain: The SpEYE Study. The Journal of rheumatology 49 (7) (2022)
Bart F Seppen, Jimmy Wiegel, Marieke M Ter Wee, Dirkjan van Schaardenburg, Leo D Roorda, Michael T Nurmohamed, Maarten Boers, Wouter H Bos
Smartphone-Assisted Patient-Initiated Care Versus Usual Care in Patients With Rheumatoid Arthritis and Low Disease Activity: A Randomized Controlled Trial. Arthritis & rheumatology (Hoboken, N.J.) 74 (11) (2022)
Willem F Lems, Maarten Boers, Ronald F Van Vollenhoven, Mike Nurmohamed
Antirheumatic drugs for cardiovascular disease prevention: the case for colchicine. RMD open 7 (1) (2021)
Laurette van Boheemen, Samina Turk, Marian van Beers-Tas, Wouter Bos, Diane Marsman, Ed N Griep, Mirian Starmans-Kool, Calin D Popa, Alper van Sijl, Maarten Boers, Michael T Nurmohamed, Dirkjan van Schaardenburg
Atorvastatin is unlikely to prevent rheumatoid arthritis in high risk individuals: results from the prematurely stopped STAtins to Prevent Rheumatoid Arthritis (STAPRA) trial. RMD open 7 (1) (2021)
Kim Suzanne Thomas, Christian J Apfelbacher, Joanne R Chalmers, Eric Lawrence Simpson, Phyllis I Spuls, Louise A A Gerbens, Hywel C Williams, Jochen Schmitt, Michaela Gabes, Laura M Howells, Beth L Stuart, Erin E Grinich, T Pawlitschek, T Burton, L Howie, A Gadkari, Laurent Eckert, T Ebata, Maarten Boers, H Saeki, Takeshi Nakahara, Norito Katoh
Recommended core outcome instruments for health-related quality of life, long-term control and itch intensity in atopic eczema trials: results of the HOME VII consensus meeting. The British journal of dermatology 185 (1) (2021)
Marwan Bukhari, Nicola J Goodson, Maarten Boers
Paradoxically protective effect of glucocorticoids on bone mass and fragility fracture in a large cohort: a cross-sectional study . Rheumatology advances in practice 6 (2) (2021)
Linda Hartman, Maurizio Cutolo, Reinhard Bos, Daniela Opris-Belinski, Marc R Kok, Hanneke J R M Griep-Wentink, Ruth Klaasen, Cornelia F Allaart, George A W Bruyn, Hennie G Raterman, Marieke J H Voshaar, Nuno Gomes, Rui M A Pinto, L Thomas Klausch, Willem F Lems, Maarten Boers
Medication adherence in older people with rheumatoid arthritis is lower according to electronic monitoring than according to pill count. Rheumatology (Oxford, England) 60 (11) (2021)
M J J Lucassen, Marieke M Ter Wee, D den Uyl, N P C Konijn, Michael T Nurmohamed, Alexandre E Voskuyl, Dirkjan van Schaardenburg, P J S M Kerstens, Irene E M Bultink, Maarten Boers, Willem F Lems
Long-term effects on bone mineral density after four years of treatment with two intensive combination strategies, including initially high-dose prednisolone, in early rheumatoid arthritis patients: the COBRA-light trial. Osteoporosis international : a journal established as result of cooperation between the European Foundation for Osteoporosis and the National Osteoporosis Foundation of the USA 32 (7) (2021)
Ellen Bernadette Maria Elsman, Leo D Roorda, Martine H P Crins, Maarten Boers, Caroline B Terwee
Dutch reference values for the Patient-Reported Outcomes Measurement Information System Scale v1.2 - Global Health (PROMIS-GH). Journal of patient-reported outcomes 5 (1) (2021)
Annelies Boonen, Polina Putrik, Mary Lucy Marques, Alessia Alunno, Lydia Abasolo, Dorcas Beaton, Neil Betteridge, Mathilda Bjørk, Maarten Boers, Boryana Boteva, Bruno Fautrel, Francis Guillemin, Elsa F Mateus, Elena Nikiphorou, Márta Péntek, Fernando Pimentel Santos, Johannes L Severens, Suzanne M M Verstappen, Karen Walker-Bone, Johan Karlsson Wallman, Marieke M Ter Wee, René Westhovens, Josef S Smolen
EULAR Points to Consider (PtC) for designing, analysing and reporting of studies with work participation as an outcome domain in patients with inflammatory arthritis. Annals of the rheumatic diseases 80 (9) (2021)
Qiuke Wang, Jos Runhaar, Margreet Kloppenburg, Maarten Boers, Johannes W J Bijlsma, Sita M A Bierma-Zeinstra, null null
The Added Value of Radiographs in Diagnosing Knee Osteoarthritis Is Similar for General Practitioners and Secondary Care Physicians; Data from the CHECK Early Osteoarthritis Cohort. Journal of clinical medicine 9 (10) (2020)
Andriko Palmowski, Sabrina M Nielsen, Thomas Buttgereit, Yannick Palmowski, Maarten Boers, Robin Christensen, Frank Buttgereit
Association Between Participant Retention and the Proportion of Included Elderly People in Rheumatology Trials: Results From a Series of Exploratory Meta-Regression Analyses. Arthritis care & research 72 (10) (2020)
Sabrina Mai Nielsen, Marianne Uggen Rasmussen, Maarten Boers, Danielle A van der Windt, Maarten P T de Wit, Thasia G Woodworth, Caroline A Flurey, Dorcas E Beaton, Beverley Shea, Reuben Escorpizo, Daniel E Furst, Josef S Smolen, Karine Toupin April, Annelies Boonen, Marieke Voshaar, Torkell J Ellingsen, George A Wells, Barnaby C Reeves, Lyn M March, Peter Tugwell, Robin Christensen
Towards consensus in defining and handling contextual factors within rheumatology trials: an initial qualitative study from an OMERACT working group. Annals of the rheumatic diseases 80 (2) (2020)
Lea C Berkhout, Merel J l'Ami, Jill Ruwaard, Margreet H Hart, Pleuni Ooijevaar-de Heer, Karien Bloem, Michael T Nurmohamed, Ronald F van Vollenhoven, Maarten Boers, Daniel F Alvarez, Catherine H Smith, Gerrit J Wolbink, Theo Rispens
Dynamics of circulating TNF during adalimumab treatment using a drug-tolerant TNF assay. Science translational medicine 11 (477) (2020)
Bart F Seppen, Jimmy Wiegel, Merel J l'Ami, Sharon Duarte Dos Santos Rico, Fabio S Catarinella, Franktien Turkstra, Maarten Boers, Wouter H Bos
Feasibility of Self-Monitoring Rheumatoid Arthritis With a Smartphone App: Results of Two Mixed-Methods Pilot Studies. JMIR formative research 4 (9) (2020)
Maarten Boers
Patient global assessment to define remission in rheumatoid arthritis:quo vadis? Annals of the rheumatic diseases (2020)
Bart F Seppen, Merel J l'Ami, Sharon Duarte Dos Santos Rico, Marieke M Ter Wee, Franktien Turkstra, Leo D Roorda, Fabio S Catarinella, Dirkjan van Schaardenburg, Michael T Nurmohamed, Maarten Boers, Wouter H Bos
A Smartphone App for Self-Monitoring of Rheumatoid Arthritis Disease Activity to Assist Patient-Initiated Care: Protocol for a Randomized Controlled Trial. JMIR research protocols 9 (2) (2020)
Sabrina Mai Nielsen, Helene Storgaard, Torkell J Ellingsen, Beverley J Shea, George A Wells, Vivian Andrea Welch, Daniel E Furst, Maarten P T de Wit, Marieke Voshaar, Carsten Bogh Juhl, Maarten Boers, Reuben Escorpizo, Thasia G Woodworth, Annelies Boonen, Henning Bliddal, Lyn M March, Peter Tugwell, Robin Christensen
Population characteristics as important contextual factors in rheumatological trials: an exploratory meta-epidemiological study from an OMERACT Working Group. Annals of the rheumatic diseases 79 (10) (2020)
Maarten Boers
Public/private partnerships, at what price? Annals of the rheumatic diseases (2020)
Max Yates, Claire Elizabeth Owen, Sara Muller, Karly Graham, Lorna Neill, Helen Twohig, Maarten Boers, Mar Pujades Rodriguez, Susan M Goodman, Jonathan Toh Leong Cheah, Christian Dejaco, Chetan B Mukhtyar, Berit Dalsgaard Nielsen, Joanna C Robson, Lee S Simon, Beverley Shea, Sarah Louise Mackie, Catherine L Hill, null null
Feasibility and Face Validity of Outcome Measures for Use in Future Studies of Polymyalgia Rheumatica: An OMERACT Study. The Journal of rheumatology 47 (9) (2020)
Maarten Boers, Theodore Pincus
Long-term Glucocorticoid Use in Rheumatoid Arthritis. The Journal of rheumatology 48 (8) (2020)
Sabrina Mai Nielsen, Peter Tugwell, Maarten P T de Wit, Maarten Boers, Dorcas E Beaton, Thasia G Woodworth, Reuben S Escorpizo, Beverley J Shea, Karine Toupin April, Francis Guillemin, Vibeke Strand, Jasvinder A Singh, Margreet Kloppenburg, Daniel E Furst, George A Wells, Josef S Smolen, Richard Vesely, Annelies Boonen, Helene Storgaard, Marieke Voshaar, Lyn M March, Robin Christensen, null null
Identifying Provisional Generic Contextual Factor Domains for Clinical Trials in Rheumatology: Results from an OMERACT Initiative. The Journal of rheumatology 46 (9) (2019)
Toby O Smith, Gillian A Hawker, David J Hunter, Lyn M March, Maarten Boers, Beverley J Shea, Robin Christensen, Francis Guillemin, Caroline B Terwee, Paula R Williamson, Susanna Dodd, Ewa M Roos, Richard F Loeser, Thomas J Schnitzer, Margreet Kloppenburg, Tuhina Neogi, Christoph H Ladel, Gurdyal Kalsi, Ulrike Kaiser, Thomas W Buttel, Anne E Ashford, Ali Mobasheri, Nigel K Arden, Alan Tennant, Marc C Hochberg, Maarten P T de Wit, Peter Tugwell, Philip G Conaghan
The OMERACT-OARSI Core Domain Set for Measurement in Clinical Trials of Hip and/or Knee Osteoarthritis. The Journal of rheumatology 46 (8) (2019)
Rabia Agca, Luuk H G A Hopman, Koen J C Laan, Vokko P van Halm, Mike J L Peters, Yvo M Smulders, Jacqueline M Dekker, Giel Nijpels, Coen D A Stehouwer, Alexandre E Voskuyl, Maarten Boers, Willem F Lems, Michael T Nurmohamed
Cardiovascular Event Risk in Rheumatoid Arthritis Compared with Type 2 Diabetes: A 15-year Longitudinal Study. The Journal of rheumatology 47 (3) (2019)
Maarten Boers
Designing effective graphs to get your message across. Annals of the rheumatic diseases 77 (6) (2019)
Tim Pickles, Rieke E Alten, Maarten Boers, Vivian P Bykerk, Jared Christensen, Robin Christensen, Hubert van Hoogstraten, Lee S Simon, Lai Shan Tam, Ernest H S Choy
Adaptive Trial Designs in Rheumatology: Report from the OMERACT Special Interest Group. The Journal of rheumatology 46 (10) (2019)
Pomme B M Poppelaars, Lilian H D van Tuyl, Maarten Boers
Mortality has improved in RA, but we must remain vigilant. Response to: 'Early intensive treatment normalises excess mortality in ACPA-negative RA but not in ACPA-positive RA' by Matthijssen et al. Annals of the rheumatic diseases 79 (10) (2019)
Pomme B M Poppelaars, Lilian H D van Tuyl, Maarten Boers
Normal mortality of the COBRA early rheumatoid arthritis trial cohort after 23 years of follow-up. Annals of the rheumatic diseases 78 (5) (2019)
Lara J Maxwell, Dorcas E Beaton, Beverley J Shea, George A Wells, Maarten Boers, Shawna Grosskleg, Clifton O Bingham, Philip Gerard Conaghan, Maria Antonietta D'Agostino, Maarten P T de Wit, Laure Gossec, Lyn M March, Lee S Simon, Jasvinder A Singh, Vibeke Strand, Peter Tugwell
Core Domain Set Selection According to OMERACT Filter 2.1: The OMERACT Methodology. The Journal of rheumatology 46 (8) (2019)
Toby O Smith, Michael Mansfield, Gillian A Hawker, David J Hunter, Lyn M March, Maarten Boers, Beverley J Shea, Robin Christensen, Francis Guillemin, Caroline B Terwee, Paula R Williamson, Ewa M Roos, Richard F Loeser, Thomas J Schnitzer, Margreet Kloppenburg, Tuhina Neogi, Christoph H Ladel, Gurdyal Kalsi, Ulrike Kaiser, Thomas W Buttel, Anne E Ashford, Ali Mobasheri, Nigel K Arden, Alan Tennant, Marc C Hochberg, Maarten P T de Wit, Peter Tugwell, Philip G Conaghan
Uptake of the OMERACT-OARSI Hip and Knee Osteoarthritis Core Outcome Set: Review of Randomized Controlled Trials from 1997 to 2017. The Journal of rheumatology 46 (8) (2019)
Teresa A Simon, Benjamin P Soule, Marc Hochberg, Douglas Fleming, Anne Torbeyns, Subhashis Banerjee, Maarten Boers
Safety of Abatacept Versus Placebo in Rheumatoid Arthritis: Integrated Data Analysis of Nine Clinical Trials. ACR open rheumatology 1 (4) (2019)
Dorcas E Beaton, Lara J Maxwell, Beverley J Shea, George A Wells, Maarten Boers, Shawna Grosskleg, Clifton O Bingham, Philip Gerard Conaghan, Maria Antonietta D'Agostino, Maarten P T de Wit, Laure Gossec, Lyn M March, Lee S Simon, Jasvinder A Singh, Vibeke Strand, Peter Tugwell
Instrument Selection Using the OMERACT Filter 2.1: The OMERACT Methodology. The Journal of rheumatology 46 (8) (2019)
Maarten Boers, Dorcas E Beaton, Beverley J Shea, Lara J Maxwell, Susan J Bartlett, Clifton O Bingham, Philip G Conaghan, Maria Antonietta D'Agostino, Maarten P T de Wit, Laure Gossec, Lyn March, Lee S Simon, Jasvinder A Singh, Vibeke Strand, George A Wells, Peter Tugwell
OMERACT Filter 2.1: Elaboration of the Conceptual Framework for Outcome Measurement in Health Intervention Studies. The Journal of rheumatology 46 (8) (2019)
Merel J l'Ami, Charlotte L Krieckaert, Michael T Nurmohamed, Ronald F van Vollenhoven, Theo Rispens, Maarten Boers, Gerrit Jan Wolbink
Response to: 'Tapering without relapse in rheumatoid arthritis patients with high TNF blocker concentrations: data from the STRASS study' by Marotte et al. Annals of the rheumatic diseases 79 (7) (2019)
Maarten Boers, Jasvinder A Singh, Stacey S Cofield, S Louis Bridges, Larry W Moreland, James R O'Dell, Hongsheng Wu, Sarah Leatherman, Jeffrey R Curtis
A Novel Method to Combine Assessment of Benefit and Harm: Outcome Measures in Rheumatology 3×3 Methodology Applied to Two Active Comparator Trials. Arthritis care & research 71 (2) (2019)
Maarten Boers
Effects of Co-medication with Glucocorticoids in Biologics Trials. The Journal of rheumatology 45 (11) (2018)
Merel J l'Ami, Charlotte Lm Krieckaert, Michael T Nurmohamed, Ronald F van Vollenhoven, Theo Rispens, Maarten Boers, Gerrit Jan Wolbink
Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial. Annals of the rheumatic diseases 77 (4) (2017)
Maarten Boers
Graphics and statistics for cardiology: designing effective tables for presentation and publication. Heart (British Cardiac Society) 104 (3) (2017)
Josef S Smolen, Robert Landewé, Johannes Bijlsma, Gerd Burmester, Katerina Chatzidionysiou, Maxime Dougados, Jackie Nam, Josef S Smolen, Marieke Voshaar, Ronald van Vollenhoven, Daniel Aletaha, Martin Aringer, Maarten Boers, Chris D Buckley, Frank Buttgereit, Vivian Bykerk, Mario Humberto Cardiel, Bernard Combe, Maurizio Cutolo, Yvonne van Eijk-Hustings, Paul Emery, Axel Finckh, Cem Gabay, Juan Gomez-Reino, Laure Gossec, Jacques-Eric Gottenberg, Johanna M W Hazes, Tom Huizinga, Meghna Jani, Dmitry Karateev, Marios Kouloumas, Tore Kvien, Zhanguo Li, Xavier Mariette, Iain McInnes, Eduardo Mysler, Peter Nash, Karel Pavelka, Gyula Poór, Christophe Richez, Piet van Riel, Andrea Rubbert-Roth, Kenneth Saag, José António Pereira Da Silva, Tanja Stamm, Tsutomu Takeuchi, René Westhovens, Maarten de Wit, Désirée Mfm van der Heijde
EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs: 2016 update. Annals of the rheumatic diseases 76 (6) (2017)
Merel J l'Ami, Charlotte L M Krieckaert, Michael T Nurmohamed, Ronald F van Vollenhoven, Theo Rispens, Maarten Boers, Gerrit Jan Wolbink
Response to: Comment on l'Ami et al titled 'Successful reduction of overexposure in patients with rheumatoid arthritis with high serum adalimumab concentrations: an open-label, non-inferiority, randomised clinical trial' by den Broeder et al. Annals of the rheumatic diseases 77 (10) (2017)